Search research articles
Contact Us
Filters
Showing results (861-870 of 890) with videos related to
Page
of 89
Sort By:
Clinical and Translational Medicine
|
May 28, 2021
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
Mi Yang, Xixi Wu, Lu Li, et al.
International Journal of Oncology
|
May 12, 2018
Comprehensive analysis of the clinical significance and prospective molecular mechanisms of differentially expressed autophagy-related genes in thyroid cancer
Peng Lin, Yun He, Dong-Yue Wen, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
September 28, 2011
[Using barium fluoride fine particles as stationary phase for TLC/FTIR analysis]
Xi Liu, Qing-hua Pan, Jie Ding, et al.
JCI Insight
|
April 20, 2018
Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis
Ashraf Ul Kabir, Tae-Jin Lee, Hua Pan, et al.
BMC Genomics
|
December 23, 2011
H2B ubiquitylation is part of chromatin architecture that marks exon-intron structure in budding yeast
Grace S Shieh, Chin-Hua Pan, Jia-Hong Wu, et al.
Journal of Medicinal Chemistry
|
March 4, 2020
Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein
Chia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, et al.
Nature Methods
|
November 17, 2025
A multi-omics molecular landscape of 30 tissues in aging female rhesus macaques
Gong-Hua Li, Xiang-Qing Zhu, Fu-Hui Xiao, et al.
Journal of Hepatology
|
February 1, 2022
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma
Mi Yang, Xixi Wu, Jinlong Hu, et al.
Molecular Medicine Reports
|
July 25, 2020
Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer
Xiao-Jiao Li, Rong Wen, Dong-Yue Wen, et al.
Asian Journal of Andrology
|
December 20, 2022
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
Xin-Xing Du, Yan-Hao Dong, Han-Jing Zhu, et al.
Page
of 89
Search research articles
Search
Showing results (861-870 of 890) with videos related to
Sort By:
Page
of 89
Clinical and Translational Medicine
|
May 28, 2021
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
Mi Yang, Xixi Wu, Lu Li, et al.
International Journal of Oncology
|
May 12, 2018
Comprehensive analysis of the clinical significance and prospective molecular mechanisms of differentially expressed autophagy-related genes in thyroid cancer
Peng Lin, Yun He, Dong-Yue Wen, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
September 28, 2011
[Using barium fluoride fine particles as stationary phase for TLC/FTIR analysis]
Xi Liu, Qing-hua Pan, Jie Ding, et al.
JCI Insight
|
April 20, 2018
Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis
Ashraf Ul Kabir, Tae-Jin Lee, Hua Pan, et al.
BMC Genomics
|
December 23, 2011
H2B ubiquitylation is part of chromatin architecture that marks exon-intron structure in budding yeast
Grace S Shieh, Chin-Hua Pan, Jia-Hong Wu, et al.
Journal of Medicinal Chemistry
|
March 4, 2020
Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein
Chia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, et al.
Nature Methods
|
November 17, 2025
A multi-omics molecular landscape of 30 tissues in aging female rhesus macaques
Gong-Hua Li, Xiang-Qing Zhu, Fu-Hui Xiao, et al.
Journal of Hepatology
|
February 1, 2022
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma
Mi Yang, Xixi Wu, Jinlong Hu, et al.
Molecular Medicine Reports
|
July 25, 2020
Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer
Xiao-Jiao Li, Rong Wen, Dong-Yue Wen, et al.
Asian Journal of Andrology
|
December 20, 2022
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
Xin-Xing Du, Yan-Hao Dong, Han-Jing Zhu, et al.
Page
of 89